Regenerx Biopharmaceuticals

OTC: RGRX    
Share price (5/1/24): $0.00    
Market cap (5/1/24): $211 thousand
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.65
from 8-K 2 pages Material contract
12/34/56
EX-10.64
from 8-K 8 pages Regenerx Biopharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.63
from 8-K 6 pages Convertible Promissory Note
12/34/56
EX-10.5
from 10-Q 4 pages ​ Lock-Up Agreement
12/34/56
EX-10.4
from 10-Q 23 pages Regenerx Biopharmaceuticals, Inc
12/34/56
EX-10.3
from 10-Q 20 pages Series a Common Stock Purchase Warrant
12/34/56
EX-10.2
from 10-Q 28 pages ​ Registration Rights Agreement
12/34/56
EX-10.1
from 10-Q 42 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 10-Q 9 pages Regenerx Biopharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.2
from 10-Q 6 pages Convertible Promissory Note
12/34/56
EX-10.1
from 10-Q 20 pages Regenerx Biopharmaceuticals, Inc. Convertible Note and Warrant Purchase Agreement October 15, 2020
12/34/56
EX-10.2
from 10-Q 3 pages Amendment No. 1 to Rgn-259 License Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Amendment N. 1 to License Agreement
12/34/56
EX-10.3
from 10-Q 9 pages Regenerx Biopharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.2
from 10-Q 6 pages Convertible Promissory Note
12/34/56
EX-10.1
from 10-Q 21 pages Regenerx Biopharmaceuticals, Inc. Convertible Note and Warrant Purchase Agreement February [__], 2019
12/34/56
EX-10.49
from 10-K 17 pages Regenerx Biopharmaceuticals, Inc. 2018 Equity Incentive Plan Adopted by the Board of Directors Effective as of & Approved by the Stockholders: June 13, 2018 Termination Date: June 13, 2028
12/34/56
EX-10.48
from 10-K 19 pages Common Stock Purchase Warrant Regenerx Biopharmaceuticals, Inc
12/34/56
EX-10.47
from 10-K 7 pages Regenerx Biopharmaceuticals, Inc
12/34/56
EX-10.1
from 10-Q 4 pages Amendment No. 2 to Rgn-137 License Agreement
12/34/56